These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25689736)

  • 1. Studies and methodologies on vaginal drug permeation.
    Machado RM; Palmeira-de-Oliveira A; Gaspar C; Martinez-de-Oliveira J; Palmeira-de-Oliveira R
    Adv Drug Deliv Rev; 2015 Sep; 92():14-26. PubMed ID: 25689736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vagina as a route for systemic drug delivery.
    Hussain A; Ahsan F
    J Control Release; 2005 Mar; 103(2):301-13. PubMed ID: 15763615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive and thermogelling systems for vaginal drug delivery.
    Caramella CM; Rossi S; Ferrari F; Bonferoni MC; Sandri G
    Adv Drug Deliv Rev; 2015 Sep; 92():39-52. PubMed ID: 25683694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical assessments of vaginal microbicide candidate safety and efficacy.
    Fernández-Romero JA; Teleshova N; Zydowsky TM; Robbiani M
    Adv Drug Deliv Rev; 2015 Sep; 92():27-38. PubMed ID: 25543007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ex vivo protocol using porcine vagina to assess drug permeation from mucoadhesive and colloidal pharmaceutical systems.
    Pereira MN; Reis TA; Matos BN; Cunha-Filho M; Gratieri T; Gelfuso GM
    Colloids Surf B Biointerfaces; 2017 Oct; 158():222-228. PubMed ID: 28697437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances on anti-HIV vaginal delivery systems development.
    Antimisiaris SG; Mourtas S
    Adv Drug Deliv Rev; 2015 Sep; 92():123-45. PubMed ID: 25858666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why consider vaginal drug administration?
    Alexander NJ; Baker E; Kaptein M; Karck U; Miller L; Zampaglione E
    Fertil Steril; 2004 Jul; 82(1):1-12. PubMed ID: 15236978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special issue on vaginal drug delivery.
    de Oliveira RP; de Oliveira JM; Caramella C
    Adv Drug Deliv Rev; 2015 Sep; 92():1. PubMed ID: 26452325
    [No Abstract]   [Full Text] [Related]  

  • 9. Taxifolin: Evaluation Through Ex vivo Permeations on Human Skin and Porcine Vaginal Mucosa.
    Alves MC; de Almeida PA; Polonini HC; Bhering CAP; de O Ferreira A; Brandao MAF; Raposo NRB
    Curr Drug Deliv; 2018; 15(8):1123-1134. PubMed ID: 29336264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies for local treatment of vaginal infections.
    Palmeira-de-Oliveira R; Palmeira-de-Oliveira A; Martinez-de-Oliveira J
    Adv Drug Deliv Rev; 2015 Sep; 92():105-22. PubMed ID: 26144995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy.
    Woodsong C; Holt JD
    Adv Drug Deliv Rev; 2015 Sep; 92():146-54. PubMed ID: 25703190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.
    Squier CA; Mantz MJ; Schlievert PM; Davis CC
    J Pharm Sci; 2008 Jan; 97(1):9-21. PubMed ID: 17721937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery by the intravaginal route.
    Woolfson AD; Malcolm RK; Gallagher R
    Crit Rev Ther Drug Carrier Syst; 2000; 17(5):509-55. PubMed ID: 11108158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
    Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
    Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovations in bioadhesive vaginal drug delivery system.
    Bassi P; Kaur G
    Expert Opin Ther Pat; 2012 Sep; 22(9):1019-32. PubMed ID: 22860765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.
    Van Gele M; Geusens B; Brochez L; Speeckaert R; Lambert J
    Expert Opin Drug Deliv; 2011 Jun; 8(6):705-20. PubMed ID: 21446890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal mucoadhesive drug delivery systems.
    de Araújo Pereira RR; Bruschi ML
    Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-based nanocarriers for vaginal drug delivery.
    das Neves J; Nunes R; Machado A; Sarmento B
    Adv Drug Deliv Rev; 2015 Sep; 92():53-70. PubMed ID: 25550217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gels as vaginal drug delivery systems.
    das Neves J; Bahia MF
    Int J Pharm; 2006 Aug; 318(1-2):1-14. PubMed ID: 16621366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Trends and Potential Prospects in Vaginal Drug Delivery.
    Mahant S; Sharma AK; Gandhi H; Wadhwa R; Dua K; Kapoor DN
    Curr Drug Deliv; 2023; 20(6):730-751. PubMed ID: 35422213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.